EM2109E "CAR T cell therapy - the future beyond hematological malignancies!" (IM GR-092421)

This presentation will provide the current understanding of treatment landscape in FDA Approved CAR-T Cell Therapy. Listeners will be able to understand the barriers in wide-scale implementation of CAR-T therapy along with potential solutions to expand utilization beyond hematological malignancies

Target Audience

UT Southwestern faculty, fellows, residents and medical students, community physicians, nurse clinicians, physician assistants and nurses.

Learning Objectives

At the conclusion of this activity, the participant should be able to:

  • Describe the current treatment landscape of CAR-T Cell therapy in FDA approved indications
  • Explain the applicability of CAR-T Cell therapy in non-hematological indications
  • Identify the challenges and solutions facing future wide-scale implementation of CAR-T Cell therapy
Course summary
Available credit: 
  • 1.00 AMA
Course opens: 
09/28/2021
Course expires: 
10/29/2021
Cost:
$0.00
Rating: 
0

Photo: Ankit Kansagra, M.D.Ankit Kansagra, M.D.
Assistant Professor of Internal Medicine
Division of Hematology and Oncology

Available Credit

  • 1.00 AMA

Price

Cost:
$0.00
Please login or create an account to take this course.

Required Hardware/software

Activities should be run with recent versions of common browsers, including Internet Explorer, Firefox and Google Chrome